(18.225.31.159)
Users online: 7935     
Ijournet
Email id
 

Year : 2023, Volume : 25, Issue : 4
First page : ( 417) Last page : ( 423)
Print ISSN : 0972-0979. Online ISSN : 0974-4517. Published online : 2023 December 10.
Article DOI : 10.5958/0974-4517.2023.00047.2

Evaluation of Antimicrobial Properties of Adiantum latifolium Lam.: A Source of Triterpenoid Leads Against Pathogenic Bacteria

Siddique Simna, Nair Arya R., Kumar R. Pradeep*, Kumar Praveen, Chithra S.K. Jaya

Post Graduate and Research Department of Zoology, Government College for Women, Thiruvananthapuram - 695 014, Kerala (India)

*e-mail: pradeepnta2005@gmail.com

Online Published on 10 November, 2023.

Received:  18  ,  2023; Accepted:  09  ,  2023.

Abstract

Secondary bacterial infections and the emergence of drug resistant microbial strains are two consequences concomitant with COVID-19 pandemic. It demands novel antibacterial drugs to treat secondary bacterial diseases. The present study reveals that the ethyl acetate extract of the leaves of A. latifolium has antibacterial efficacy against six pathogenic bacteria, viz., Bacillus cereus, Staphylococcus aureus, Proteus mirabilis, Pseudomonas aeruginosa, Escherichia coli and Klebsiella pneumonia, reported to be infecting COVID-19 patients. Molecular docking and FTIR studies have been used to find out the lead molecules of the extract. The triterpenoids 22-hydroxyhopane and 3β-acetoxy-21α-H-hop-22(29)ene have shown high binding affinity (binding energy from -6.82 to -9.28 kcal mol−1) with DNA gyrase and penicillin binding proteins provided as targets. The study indicates that the phytocompounds present in A. latifolium may serve to combat COVID-19 associated ailments.

Top

Keywords

Adiantum latifolium, 3p-acetoxy-21a-H-hop-22(29)ene, Covid- 19, FTIR, 22-hydroxyhopane, Molecular docking.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
746,651,070 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.